Advertisement
Digestive Endoscopy| Volume 49, ISSUE 10, P1115-1120, October 2017

Download started.

Ok

Surveillance after positive colonoscopy based on adenoma characteristics

  • Ido Laish
    Correspondence
    Corresponding author at: Gastroenterology and Hepatology Institute, Meir Medical Center, 59 Tschernihovsky St., Kfar Saba 44281, Israel. Fax: +972 9 7471320.
    Affiliations
    Gastroenterology and Hepatology Institute, Meir Medical Center, Kfar Saba, Israel

    Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author
  • Ilia Seregeev
    Affiliations
    Gastroenterology and Hepatology Institute, Meir Medical Center, Kfar Saba, Israel
    Search for articles by this author
  • Timna Naftali
    Affiliations
    Gastroenterology and Hepatology Institute, Meir Medical Center, Kfar Saba, Israel

    Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author
  • Fred M. Konikoff
    Affiliations
    Gastroenterology and Hepatology Institute, Meir Medical Center, Kfar Saba, Israel

    Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author

      Abstract

      Background

      Patients with adenomatous polyps are at increased risk for developing colorectal cancer based on the characteristics and number of polyps, but less is known about the individual and combined contribution of these factors. This study aimed to better characterize the risk of advanced adenoma and cancer in patients with positive baseline colonoscopy.

      Methods

      Patients who had polyps at baseline colonoscopy were included in this retrospective cohort study (N = 1165) and were categorized into 6 groups: (1) 1–2 non-advanced adenomas (NAA’s), (2) ≥3 NAA’s, (3) advanced tubular adenoma, (4) small tubulovillous adenoma (TVA), (5) large TVA and (6) multiple advanced adenomas (MAA’s). Findings at surveillance colonoscopy were documented in each group.

      Results

      The combined incidence of advanced adenoma,  ≥3 NAA’s, and colorectal cancer at surveillance colonoscopy was significantly higher in the baseline large TVA (29.2%) than small TVA groups (13.5%, P< 0.001), as well as in the MAA’s group (44.1%) compared with large TVA group (P= 0.02). The incidence of colorectal cancer, however, was not significantly different between the groups.

      Conclusions

      The size of the polyp and the number of advanced lesions are more important than its histology for predicting the risk of high-risk metachronous lesions at follow-up.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zauber A.G.
        • Winawer S.J.
        • O’Brien M.J.
        • et al.
        Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.
        The New England Journal of Medicine. 2012; 366: 687-696
        • Lieberman D.A.
        • Rex D.K.
        • Winawer S.J.
        • et al.
        Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society task Force on Colorectal cancer.
        Gastroenterology. 2012; 143: 844-857
        • Atkin W.S.
        • Valori R.
        • Kuipers E.J.
        • et al.
        European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition — colonoscopic surveillance following adenoma removal.
        Endoscopy. 2012; 44: SE151-SE163
        • Cairns S.R.
        • Scholefield J.H.
        • Steele R.J.
        • et al.
        Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).
        Gut. 2010; 59: 666-689
        • Martinez M.E.
        • Baron J.A.
        • Lieberman D.A.
        • et al.
        A pooled analysis of advanced colorectal neoplasia diagnoses following colonoscopic polypectomy.
        Gastroenterol. 2009; 136: 832-841
        • Saini S.D.
        • Kim H.M.
        • Schoenfeld P.
        Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review.
        Gastrointestinal Endoscopy. 2006; 64: 614-626
        • Lieberman D.A.
        • Weiss D.G.
        • Harford W.V.
        • et al.
        Five-year colon surveillance after screening colonoscopy.
        Gastroenterology. 2007; 133: 1077-1085
        • Miller H.L.
        • Mukherjee R.
        • Tian J.
        • et al.
        Colonoscopy surveillance after polypectomy may be extended beyond five years.
        Journal of Clinical Gastroenterology. 2010; 44: e162-e166
        • Cottet V.
        • Jooste V.
        • Fournel I.
        • et al.
        Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study.
        Gut. 2012; 61: 1180-1186
        • Chung S.J.
        • Kim Y.S.
        • Yang S.Y.
        • et al.
        Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.
        Gut. 2011; 60: 1537-1543
        • Hassan C.
        • Quintero E.
        • Dumonceau J.M.
        • et al.
        Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
        Endoscopy. 2013; 45: 842-851
        • Rothwell P.M.
        • Wilson M.
        • Elwin C.E.
        • et al.
        Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
        Lancet. 2010; 376: 1741-1750
        • Morales T.G.
        • Sampliner R.E.
        • Garewal H.S.
        • et al.
        The difference in colon polyp size before and after removal.
        Gastrointestinal Endoscopy. 1996; 43: 25-28
        • Eichenseer P.J.
        • Dhanekula R.
        • Jakate S.
        • et al.
        Endoscopic mis-sizing of polyps changes colorectal cancer surveillance recommendations.
        Diseases of the Colon and Rectum. 2013; 56: 315-321
        • Anderson B.W.
        • Smyrk T.C.
        • Anderson K.S.
        • et al.
        Endoscopic overestimation of colorectal polyp size.
        Gastrointestinal Endoscopy. 2016; 83: 201-208
        • Moug S.J.
        • Vernall N.
        • Saldanha J.
        • et al.
        Endoscopists’ estimation of size should not determine surveillance of colonic polyps.
        Colorectal Disease. 2010; 12: 646-650
        • Schoen R.E.
        • Gerber L.D.
        • Margulies C.
        The pathologic measurement of polyp size is preferable to the endoscopic estimate.
        Gastrointestinal Endoscopy. 1997; 46: 492-496
        • Gupta S.
        • Jacobs E.T.
        • Baron J.A.
        • et al.
        Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis.
        Gut. 2015; 11: 2015-310196
        • Ladabaum U.
        • Schoen R.E.
        Post-polypectomy surveillance that would please goldilocks-not too much, not too little, but just right.
        Gastroenterol. 2016; 150: 791-796